We are pleased to share that the Vaccine Formulation Institute has been awarded new funding from the Gates Foundation under the Global Health Discovery Collaboratory (GHDC) initiative.
This two-year grant (USD 1,989,401) will support our program “Adjuvant Supply and Formulation Support for Vaccine Development”.
Through this program, VFI will provide adjuvants and formulation expertise to Gates Foundation grantees and partners via the GHDC platforms. This includes access to VFI’s portfolio of adjuvants, all of which are available at GMP grade, allowing a seamless transition from research to clinical development.